Sarepta Therapeutics
SRPT
SRPT
365 hedge funds and large institutions have $10.9B invested in Sarepta Therapeutics in 2019 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 126 increasing their positions, 116 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.11% more ownership
Funds ownership: 96.48% → 96.59% (+0.11%)
3% less first-time investments, than exits
New positions opened: 59 | Existing positions closed: 61
2% less funds holding
Funds holding: 371 → 365 (-6)
Holders
365
Holding in Top 10
13
Calls
$550M
Puts
$440M
Top Buyers
| 1 | +$118M | |
| 2 | +$115M | |
| 3 | +$83.1M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$82.4M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$62.6M |
Top Sellers
| 1 | -$267M | |
| 2 | -$68.4M | |
| 3 | -$52M | |
| 4 |
BlackRock
New York
|
-$40.2M |
| 5 |
SIG
Senator Investment Group
New York
|
-$37M |